Table 2. Characteristics of patients without CNS relapse of systemic DLBCL.
| Patient No. | Gender | Age at Dx. of DLBCL | Site of diagnostic systemic tissue biopsy | Risk factors for CNS involvement at initial diagnosis | CNS-IPIrisk group (score) | ||
|---|---|---|---|---|---|---|---|
| Site specific | Extranodal sites | BM / Para-meningeal involvement | |||||
| 21 | F | 69 | Lymph node | 2 | yes/no | IR (3) | |
| 22 | M | 38 | Liver | 2 | no/no | IR (3) | |
| 23 | F | 52 | Stomach | 2 | yes/no | IR (3) | |
| 24 | M | 79 | Colon | >1 | no/no | IR (3) | |
| 25 | M | 73 | Thoracic mass | 2 | no/no | IR (3) | |
| 26 | F | 46 | Kidney | Kidney | 1 | no/no | IR (3) |
| 27 | M | 61 | Lymph node | >1 | no/no | IR (2) | |
| 28 | F | 77 | Omentum | >1 | no/no | IR (3) | |
| 29 | F | 74 | Lymph node | 3 | no/no | IR (3) | |
| 30 | F | 79 | Lymph node | 3 | yes/no | HR (4) | |
| 31 | F | 72 | Liver | 3 | yes/no | HR (5) | |
| 32 | F | 48 | Lymph node | 2 | no/yes | IR (2) | |
| 33 | M | 66 | Mediastinal mass | 2 | no/no | HR (4) | |
| 34 | F | 62 | Colon | 2 | no/no | HR (4) | |
| 35 | F | 65 | Gastric antrum | 3 | no/yes | IR (3) | |
| 36 | M | 43 | Liver | 3 | no/no | HR (4) | |
Dx. = diagnosis; BM=bone marrow involvement; M=male; F=female; CNS-IPI=central nervous system-international prognostic index; Risk groups: LR=low risk, IR=intermediate risk; HR=high risk.